Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Pluvicto pronunciation?Does body weight affect advil's long term side effects?Is Olmesartan an angiotensin receptor blocker?Lorazepam memory loss?Pluvicto side effects?
See the DrugPatentWatch profile for Ezetimibe
Ezetimibe lowers cholesterol by blocking intestinal cholesterol absorption. It targets the Niemann-Pick C1–like 1 (NPC1L1) transport protein at the brush border of enterocytes (intestinal cells), which reduces uptake of dietary and biliary cholesterol into the body. With less cholesterol absorbed, the liver takes up more cholesterol from the bloodstream, which helps lower LDL cholesterol levels 1.
Because it acts on NPC1L1-mediated uptake of cholesterol in the intestine, ezetimibe mainly impacts cholesterol absorption rather than directly changing cholesterol synthesis in the liver. By reducing absorption of cholesterol (and related sterols entering via the intestine), it can also lower total cholesterol and non-HDL cholesterol, though its effect sizes are generally smaller than drugs that strongly suppress hepatic cholesterol synthesis 1.
Ezetimibe is often used with statins because it works through a different pathway: statins mainly reduce cholesterol synthesis in the liver, while ezetimibe reduces cholesterol absorption in the gut. Together, they can produce larger LDL reductions than either mechanism alone 1.
NPC1L1 is responsible for transporting cholesterol from the intestinal lumen into enterocytes. Ezetimibe inhibits this transport step, so less cholesterol enters circulation through the intestinal route 1.
Other Questions About Ezetimibe :